Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2014

Dec 17, 2014

31580_dirs_2014-12-17_8f32a60c-263f-44e8-a08f-7a9eb375cf60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-12-15

Reporting Person: Cantley Lewis Clayton Jr. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-15 Common stock G 181818 $0.00 Disposed 181818 Direct
2014-12-15 Common stock G 181818 $0.00 Acquired 181818 Indirect

Footnotes

F1: Reflects a gift of shares from the reporting person to his spouse, who shares the same household as the reporting person.

F2: Shares held by Vicki Lee Sato, who is the reporting person's spouse.